Cases & Deals

  • Home
  • Practices
  • Cardinal Health and TerraPower announce manufacturing and distribution agreement for Actinium-225

Share

Cardinal Health and TerraPower announce manufacturing and distribution agreement for Actinium-225

August 2021

Client(s) Cardinal Health, Inc.

Jones Day advised Cardinal Health, Inc. in its strategic alliance with TerraPower to advance the next generation of cancer treatment. Under the agreement, the companies will work together to develop and produce Actinium-225 for use in drug development and commercial sales.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.